Developments in multiple myeloma - immunotherapy and personalized medicine
CLL update from ICML17: Current treatment and future directions for patients
Targeted therapies for CLL: new data and unanswered questions
Lessons from the ASPIRE trial: three drug regimens as the new SOC for relapsed MM
The exciting field of imaging in multiple myeloma
Jens Hillengass et al.